ArticlePharmaceutics2024

Investigation of Blood Count-Based Inflammatory Biomarkers as Predictors of Response to Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps.

Michael Habenbacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.